Disrupting protein-protein interactions with aptamers Pushing for a new paradigm in disease management Optimer binders: Picking up the pace of development Synthesizing new solutions for small molecule antibodies Building better biosensor blueprints with aptamers QSM Diagnostics: Spying on bacteria for rapid diagnostic applications ADC Development: Targeted Treatment
